Upload
linda-sparks
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
Avapro / Avalide Recovery Plan
Sales Rep ToolsHarrisburg DistrictOctober 4, 2006
Prepared and delivered by Jim Brown
Plan Premise
• Q2 SGA performance favorable
• Q3-to-date market share and volume performance stabilized with slight improvement
• District Q3 performance behind Region, at bottom of district list
• Diovan and Benicar NRx volume trumps Avapro
Analysis Methodology
• Keep it simple
• Ensure START call plan adherence
• Increase focus: use Enhanced Rx Report– Found on e-Reports on SFO– Targets VH / H value rated docs
• Integrate MHC payor product access for greatest impact (i.e. Tier 2, available status)
AVAPRO VH / H prescribers by Territory defined by Enhanced NRx Report
# of targets: Reading = 65, HBG E = 23, HBG N = 49, HBG S = 52, Gettysburg = 32
0
5
10
15
20
25
30
35
% S
har
e
Reading HBG E HBG N HBG S Gettysburg
Brand Share Share of SuperBrand Market Weekly NRx Rpt Territory Share w/e 8/25
AVALIDE VH / H prescribers by Territory defined by Enhanced NRx Report
# of targets: Reading = 65, HBG E = 26, HBG N = 41, HBG S = 50, Gettysburg = 41
0
5
10
15
20
25
30
35
40
45
% S
har
e
Reading HBG E HBG N HBG S Gettysburg
Brand Share Share of SuperBrand Market Weekly NRx Rpt Territory Share w/e 8/25
This report provides focused sorting and targeting of highest value targetsusing 12 Wk NRx Brand and Market Volumes
(Note: Market volume reflects SuperBrand scripts)(Note worksheet tabs: all products are included in this report)
Zip Code
Rating
(VH,H Only) Prescriber
Primary Specialty
12 Wk NRx Brand Vol
12 Wk NRx Market Vol
TERRITORY TOTAL 834 10,366
17356 H DEHART, DRAKE PC 11 153
17011 H GUSTAVSON, ROGER IM 1 94
17011 H FRANTZ, KATHRYN IM 0 89
17344 VH HESS, RUSSELL PC 8 82
17331 VH LUNSFORD, JOHN PC 11 74
17403 VH GLORIOSO, ROBERT PC 1 72
17011 H EHGARTNER, GREGORY IM 0 71
17313 VH KRESGE, DALE IM 4 71
17402 H BRADLEY, CRAIG PC 1 67
17011 H CONNER, KENNETH IM 3 66
17331 H PECK, MICHAEL PC 1 65
17403 H BEEKEY, CYRUS IM 7 64
• Hide irrelevant columns in Report for side-by-side NRx and Market Volume comparison to reveal doc-by-doc potential.• Integrate MHC payor status by practice to proactively eliminate “cost” objection.• Remember, Market Vol. reflects SuperBrand, not ARB or ARB/HCT individual markets.
Example: HBG S., top 12 market potential docs, average at least 5 market NRx/Week.Look at brand potential!
Next Steps• Use CallMax queries and Excel analysis to
target remaining brand & superbrand potential, that is, M, L, VL rated docs representing the following business spread in the HBG District:
M, L, VL Docs Remaining
Brand Share
M, L, VL Docs Remaining
Share of Market
Avapro 65-85% 75-87%
Avalide 58-80% 68-86%
Next Steps
• Capture MHC payor prevalence by territory, followed by tops docs sorting by payor, for focused MHC messaging execution. (see examples)
• Create MHC status grid for Avapro / Avalide and competitors for rep training.
MHC Plan / Payor Prevalence in BMS HBG South TerritoryBased on 26 Weeks of CallMax NRx Data, 353 Prescribers, thru June 2006
0
500
1000
1500
2000
2500
MH
C P
lan
Pre
va
len
ce
Cu
mu
lati
ve
NR
x V
olu
me
%
PACE
Last Name First Name City (Primary) Zip AVP NRx AVL NRx Diovan NRx Benicar NRx PACE (PA)
ALEXANDROV MARIA HANOVER 17331 0 5 0 1 28
SCARITO ELIZABETH YORK 17402 3 5 1 0 26
HENDERSON CAROL YORK 17402 0 0 0 0 25
JACOBUS PAULA YORK 17402 3 6 25 6 24
MILLS JAMES YORK 17403 0 0 4 0 23
FREER LAWRENCE HANOVER 17331 3 0 5 1 21
TESTA DONNA YORK 17403 0 0 12 0 21
WOERTHWEIN KENNETH YORK 17404 6 3 37 3 21
DEPAMPHILIS HY HANOVER 17331 5 3 23 0 20
HEIRD STEVEN YORK 17403 0 0 0 0 20
MAHMUD RIFFAT SHREWSBURY 17361 2 4 16 11 20
MANZELLA JOHN YORK 17405 10 7 32 0 20
NICHOLSON W YORK 17403 0 0 0 0 20
SIDDIQUI KHALID HANOVER 17331 1 0 11 0 20
CARPENTER CATHY YORK 17403 9 3 26 2 19
GARCIA MICHAEL HANOVER 17331 7 0 4 5 19
LYND CLIFFORD YORK 17403 0 0 0 0 19
MANNING CATHY YORK 17403 10 1 17 7 19
MATHEWS RAYMOND HANOVER 17331 5 10 18 5 19
TALLURI SATISH YORK 17403 6 0 9 9 19
GEISELMAN DOUGLAS YORK 17404 7 6 0 1 18
% Volume of NRx Scripts